Financial Hardship Before Diagnosis: Influence on Late-Stage Cancer Presentation and the Role of Screening.

Sara Khor^1,2, Kaiyue Yu³, Catherine R Fedorenko⁴, Scott Ramsey⁴, Zachary Rivers⁵, Karma Kreizenbeck⁴, Hiba M Khan^4,6, Li Li⁴, Shannon T Kestner⁴, C Natasha Kwendakwema⁴, Veena Shankaran⁴

¹The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA.

²Spring Health, New York, NY.

³Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA.

⁴Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.

⁵Tempus Labs, Chicago, IL.

⁶Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA.

PubMed DOI

Abstract

PURPOSE: This study investigates the relationship between prediagnosis financial hardship (FH) and cancer stage, and the mediating role of cancer screening in breast cancer. METHODS: This case-control study used linked, deidentified records from adult cancer patients diagnosed with stage I to IV solid tumors (2014-2017) from the Western Washington SEER registry, along with credit report data from…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.